Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers
NCT ID: NCT00490945
Last Updated: 2014-08-26
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
45 participants
INTERVENTIONAL
2004-07-31
2005-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
VNS for Long-COVID-19
NCT05630040
Understanding the Effects of Transauricular Vagus Nerve Stimulation on Neural Networks and Autonomic Nervous System
NCT05801809
Vagus Nerve Stimulation to Enhance Memory in Aging
NCT07214194
Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety
NCT04999709
Neural Correlates of Hypoalgesia Driven by Observation
NCT03897998
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VEC-162
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to provide written informed consent
Exclusion Criteria
* Evidence of any sleep disorder
* Psychiatric or neurological disorders
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vanda Pharmaceuticals
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marlene Dressman, PhD
Role: STUDY_DIRECTOR
Vanda Pharmaceuticals Inc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanda Investigational Site
Boston, Massachusetts, United States
Vanda Investigational Site
Detroit, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rajaratnam SM, Polymeropoulos MH, Fisher DM, Roth T, Scott C, Birznieks G, Klerman EB. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. Lancet. 2009 Feb 7;373(9662):482-91. doi: 10.1016/S0140-6736(08)61812-7. Epub 2008 Dec 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VP-VEC-162-2101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.